CN105362600A - 一种治疗化脓性感染的中药制剂 - Google Patents
一种治疗化脓性感染的中药制剂 Download PDFInfo
- Publication number
- CN105362600A CN105362600A CN201510842809.3A CN201510842809A CN105362600A CN 105362600 A CN105362600 A CN 105362600A CN 201510842809 A CN201510842809 A CN 201510842809A CN 105362600 A CN105362600 A CN 105362600A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- add
- pyogenic infection
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 20
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- 241001116389 Aloe Species 0.000 claims description 12
- 229920002125 Sokalan® Polymers 0.000 claims description 12
- 229960001631 carbomer Drugs 0.000 claims description 12
- 230000008961 swelling Effects 0.000 claims description 12
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 235000017858 Laurus nobilis Nutrition 0.000 claims description 6
- 244000125380 Terminalia tomentosa Species 0.000 claims description 6
- 235000005212 Terminalia tomentosa Nutrition 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- -1 nitrogen core ketone Chemical class 0.000 claims description 6
- 235000011837 pasties Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims 3
- 241000196324 Embryophyta Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 abstract 1
- 244000186892 Aloe vera Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 240000002779 Cayratia japonica Species 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 208000004210 Pressure Ulcer Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 201000003516 breast abscess Diseases 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010067268 Post procedural infection Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗化脓性感染的中药制剂,由乌蔹莓、芦荟组成,所选药物为纯中草药,协同配伍合理,对于手术感染或细菌感染引起的各种化脓性感染、乳腺脓肿以及术后褥疮等感染疾病疗效显著,临床症状消失迅速,具有疗程短、费用低、使用方便、毒副作用小等特点。
Description
技术领域
本发明涉及一种治疗治疗化脓性溃烂的中药制剂,尤其是涉及一种治疗手术感染或细菌感染引起的各种化脓性感染的中药制剂,属于中医制药技术领域。
背景技术
化脓性感染疾病多见于手术感染以及细菌感染所产生的并发症中,由于患者昏迷、行动不便或者久卧不能起床,常出现脓肿以及褥疮等症状导致皮肤溃烂,给患者带来几位痛苦的折磨,严重影响了患者的正常生活;同时,在治疗上也较为困难,甚至在一些卫生条件不好的地方,还会导致生虫,严重时会引起败血症、破伤风及心肺感染等疾病,令人望而生畏。目前,治疗上述疾病的药多为西药,但其临床作用的效果不好,并且价钱昂贵,长时期服用增加了患者的经济负担,副作用较大,对身体产生了其他的不良影响,治疗效果不理想。
发明内容
本发明目的在于提供一种安全有效的治疗化脓性感染的中药制剂。
本发明的另一目的是提供该中药制剂的制备方法。
本发明所提供的中药制剂是由以下重量份的中药经提取制备而成:乌蔹莓100-500份,芦荟100-500份。
本发明所述的中药制剂的制备方法,包括以下步骤:
按处方比例称取乌蔹莓、芦荟,根据以8倍量水煎提取0.5h,共提2次,浓缩提取液,烘干至浸膏,取1~3g卡波姆加适量水溶胀,滴加三乙醇胺1~5g调节pH值,另取3~8g干浸膏加少量水研至糊状,加入溶胀的卡波姆溶液中,再加入3~10g月桂氮芯酮,加水使最终质量为50~100g,搅拌均匀,即得乌蔹莓凝胶剂。
具体实施方式
下面结合具体实施例对本发明做进一步的解释。
实施例1
一种治疗化脓性感染的中药制剂,包括以下重量份数的各组分:
乌蔹莓500份,芦荟100份。
制备方法:
按处方比例取称取乌蔹莓、芦荟,根据以8倍量水煎提取0.5h,共提2次,浓缩提取液,烘干至浸膏,取1.6g卡波姆加适量水溶胀,滴加三乙醇胺3.8g调节pH值,另取2.4g干浸膏加少量水研至糊状,加入溶胀的卡波姆溶液中,再加入6g月桂氮芯酮,加水使最终质量为100g,搅拌均匀,即得乌蔹莓凝胶剂。
实施例2
一种治疗化脓性感染的中药制剂,包括以下重量份数的各组分:
乌蔹莓400份,芦荟200份。
制备方法:
按处方比例称取乌蔹莓、芦荟,根据以8倍量水煎提取0.5h,共提2次,浓缩提取液,烘干至浸膏,取2.0g卡波姆加适量水溶胀,滴加三乙醇胺3.5g调节pH值,另取5.0g干浸膏加少量水研至糊状,加入溶胀的卡波姆溶液中,再加入4.4g月桂氮芯酮,加水使最终质量为80g,搅拌均匀,即得乌蔹莓凝胶剂。
实施例3
一种治疗化脓性感染的中药制剂,包括以下重量份数的各组分:
乌蔹莓300份,芦荟200份。
制备方法:
按处方比例称取乌蔹莓、芦荟,根据以8倍量水煎提取0.5h,共提2次,浓缩提取液,烘干至浸膏,取2.6g卡波姆加适量水溶胀,滴加三乙醇胺2.8g调节pH值,另取3.4g干浸膏加少量水研至糊状,加入溶胀的卡波姆溶液中,再加入5.0g月桂氮芯酮,加水使最终质量为60g,搅拌均匀,即得乌蔹莓凝胶剂。
实施例4
一种治疗化脓性感染的中药制剂,包括以下重量份数的各组分:
乌蔹莓250份,芦荟250份。
制备方法:
按处方比例称取乌蔹莓、芦荟,根据以8倍量水煎提取0.5h,共提2次,浓缩提取液,烘干至浸膏,取2.5g卡波姆加适量水溶胀,滴加三乙醇胺2.9g调节pH值,另取5.4g干浸膏加少量水研至糊状,加入溶胀的卡波姆溶液中,再加入7g月桂氮芯酮,加水使最终质量为80g,搅拌均匀,即得乌蔹莓凝胶剂。
Claims (5)
1.一种治疗化脓性感染的中药制剂,其特征在于该组合物是由以下重量份的药用植物或饮片经提取制备而成:乌蔹莓100-500份,芦荟100-500份。
2.根据权利要求1所述的治疗化脓性感染的中药制剂,其特征在于所说的剂型是任何一种药剂学上所说的剂型。
3.根据权利要求2所述的治疗化脓性感染的药物,其特征在于所说的剂型是凝胶剂。
4.根据权利要求3所述的治疗化脓性感染的凝胶剂的制备方法,其特征在于:
按处方比例称取乌蔹莓、芦荟,根据以8倍量水煎提取0.5h,共提2次,浓缩提取液,烘干至浸膏,取1~3g卡波姆加适量水溶胀,滴加三乙醇胺1~5g调节pH值,另取3~8g干浸膏加少量水研至糊状,加入溶胀的卡波姆溶液中,再加入3~10g月桂氮芯酮,加水使最终质量为50~100g,搅拌均匀,即得乌蔹莓凝胶剂。
5.权利要求1所属的中药制剂在制备用于化脓性感染药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510842809.3A CN105362600A (zh) | 2015-11-29 | 2015-11-29 | 一种治疗化脓性感染的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510842809.3A CN105362600A (zh) | 2015-11-29 | 2015-11-29 | 一种治疗化脓性感染的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105362600A true CN105362600A (zh) | 2016-03-02 |
Family
ID=55365549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510842809.3A Pending CN105362600A (zh) | 2015-11-29 | 2015-11-29 | 一种治疗化脓性感染的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105362600A (zh) |
-
2015
- 2015-11-29 CN CN201510842809.3A patent/CN105362600A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104306514A (zh) | 一种中药喷剂及其制备方法 | |
CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN103070961A (zh) | 一种中药抑菌养生护理足浴液及其制备方法 | |
CN102266422A (zh) | 治疗轻度、重度冻疮的中药制剂及其生产方法 | |
CN106421392A (zh) | 一种治疗褥疮的中药凝胶剂及其制备方法 | |
CN100387291C (zh) | 一种治疗肺结核的药物 | |
WO2011016652A2 (ko) | 항치루 조성물 및 그 제조 방법 | |
KR20100019370A (ko) | 항치루 조성물 및 그 제조 방법 | |
CN101554449B (zh) | 一种治疗外伤的中药 | |
CN103610841A (zh) | 一种治疗竹鼠口腔炎的方法 | |
CN113730483B (zh) | 一种抑制2019新型冠状病毒的中药组合物及其应用 | |
CN105362600A (zh) | 一种治疗化脓性感染的中药制剂 | |
CN102008623A (zh) | 治疗美尼尔氏综合症的中药制剂 | |
CN101647957A (zh) | 一种烫伤药 | |
CN117462642B (zh) | 一种治疗腹泻的中药组合物及其制备方法和用途 | |
CN103599328A (zh) | 一种治疗肺泡蛋白沉着症的中药 | |
CN102008613B (zh) | 一种治疗化脓性溃烂的中药制剂 | |
CN1931278B (zh) | 一种防治冻疮的口服中成药 | |
CN106267075A (zh) | 一种用于治疗强直性脊柱炎的中药胶囊 | |
CN105213759A (zh) | 一种治疗毛囊炎的中药组合物和制备方法及其用途 | |
CN105031181A (zh) | 一种治疗风湿痹症的药酒及其制备方法 | |
CN104958460A (zh) | 治疗疥癣的外洗剂及制法 | |
CN104666784A (zh) | 一种治疗痤疮的胶囊及其制备方法 | |
CN104857383B (zh) | 一种治疗儿童恒牙根尖周炎的药物组合物及其应用 | |
CN104367934A (zh) | 一种治疗胆结石的组合物中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160302 |
|
WD01 | Invention patent application deemed withdrawn after publication |